What Are My Choices?

Case Study

Ms. Thomas is a 67 year old woman with type 2 diabetes who had a myocardial infarction 2 years ago. She is presently on metformin, DPP-4 inhibitor and a sulfonylurea. Her A1C is 7.4%.

What antihyperglycemic therapy would you offer her next?

Reveal Answer

Given that Ms. Thomas has clinical cardiovascular disease and has not met glycemic target, an antihyperglycemic agent with proven cardiovascular benefit should be added. You discuss the options of empagliflozin, liraglutide or canagliflozin with Ms. Thomas.

*The Canadian Diabetes Association is the registered owner of the name Diabetes Canada. All content on guidelines.diabetes.ca, CPG Apps and in our online store remains exactly the same. For questions, contact communication@diabetes.ca.